| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 05/18/2005 | EP1224204B1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 05/18/2005 | CN1617879A 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/18/2005 | CN1202120C Anti-pregnancy hormone active steroid with fluorated 17 alpha-alkyl-chain |
| 05/12/2005 | WO2005026083A3 Improved delivery by labile hydrophobic modification of drugs |
| 05/10/2005 | US6890533 Betulinol derivatives |
| 05/06/2005 | WO2004089304A3 Antiandrogens with marginal agonist activity and methods of use |
| 05/04/2005 | EP1307471B1 16alpha-methyl or ethyl substituted estrogens |
| 05/03/2005 | US6887991 Converting a 7-cyano substituted steroid to the corresponding 7- carboxylic acid substituted steroid, and thereafter converting the 7-carboxylic acid substituted steroid to the corresponding 5,7-lactone substituted steroid |
| 04/28/2005 | US20050090663 Carbonylation; hydrogenation; epoxidation; alkynylation; for preparation of eplerenone |
| 04/28/2005 | US20050090477 Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom |
| 04/28/2005 | US20050090476 by protecting the hydroxy group of the steroid with a trialkylsilyl group, then followed a copper mediated 1,6-conjugate addition of a grignard reagent to a 4,6-unsaturated 3-ketosteroid, to yield chemical intermediates used in hormone replacement therapy |
| 04/27/2005 | EP1525215A1 Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
| 04/27/2005 | EP1525214A2 Process and new intermediates for the preparation of steroids with a progestogen activity |
| 04/27/2005 | EP1448207B1 Dosage regimen and pharmaceutical composition for emergency contraception |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884793 Combination preparation for contraception based on natural estrogens |
| 04/21/2005 | WO2005005449A3 Steroid modified solatrioses |
| 04/21/2005 | US20050085427 Transfection agents |
| 04/20/2005 | EP1523568A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 04/20/2005 | EP1523302A2 Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations |
| 04/14/2005 | WO2005032560A2 Biological action of optically active isomers of digoxin |
| 04/14/2005 | WO2004071427A3 Screening and treatment methods for prevention of preterm delivery |
| 04/14/2005 | US20050080060 Antigestagenically active steroids with a fluorinated 17alpha-alkyl chain |
| 04/14/2005 | US20050080003 Compounds with anti-inflammatory activity |
| 04/13/2005 | EP1522543A1 Use Steroid sulphatase inhibitors for the manufacture of a medicament for the treatment of an oestrogen dependent tumour |
| 04/07/2005 | WO2005030790A1 Novel triterpene derivatives, preparation thereof and use thereof |
| 04/07/2005 | WO2005030120A2 Antiangiogenic agents |
| 04/07/2005 | US20050075322 Androgenic 7-substituted 11-halogen steroids |
| 04/07/2005 | US20050075321 Neurological disorder treatment methods |
| 04/07/2005 | US20050074771 For attachment to steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins; for detecting RNA in samples |
| 04/07/2005 | CA2540160A1 Novel triterpene derivatives, preparation thereof and use thereof |
| 04/07/2005 | CA2527074A1 Antiangiogenic agents |
| 04/06/2005 | EP1212618A4 Effect of steroids on nmda receptors depends on subunit composition |
| 04/05/2005 | CA2276146C Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2005 | WO2004098538A3 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 03/31/2005 | WO2004094449A8 Macrolide-conjugates with anti-inflammatory activity |
| 03/31/2005 | WO2002042319A9 2-substituted estrogens as antiangiogenic agents |
| 03/30/2005 | EP1517914A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 03/24/2005 | WO2005026083A2 Improved delivery by labile hydrophobic modification of drugs |
| 03/24/2005 | US20050065135 Contraceptives; side effect reduction; antitumor, anticancer agents |
| 03/24/2005 | CA2530510A1 Improved delivery by labile hydrophobic modification of drugs |
| 03/24/2005 | CA2482095A1 Method of mass spectrometry |
| 03/23/2005 | CN1599606A Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 03/16/2005 | EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 03/16/2005 | EP1513861A2 New etonogestrel esters |
| 03/16/2005 | EP1513588A2 Use of new etonogestrel esters |
| 03/16/2005 | EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides |
| 03/16/2005 | CN1594349A Process for connecting side chain to androstane compound at 17th position |
| 03/10/2005 | US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents |
| 03/10/2005 | US20050054623 Transdermal supplying testosterone gel |
| 03/10/2005 | US20050054612 In situ supplying to cells; adjust hydrophobic of drugs; drug delivery |
| 03/08/2005 | US6864248 Androgenic steroid compounds and a method of making and using the same |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/02/2005 | EP1123100B1 Improving memory by the administration of delta 5-androstene-3 beta-ol-7,17-dione and 3 beta esters thereof |
| 03/01/2005 | CA2196174C Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 02/24/2005 | WO2003090721A3 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations |
| 02/24/2005 | US20050043219 Derivatized oligonucleotides having improved uptake and other properties |
| 02/24/2005 | DE202004014858U1 Vorrichtung zur Massenspektrometrie Apparatus for mass spectrometry |
| 02/23/2005 | CN1585777A 肝脏x受体激动剂 Liver x receptor agonist |
| 02/15/2005 | US6855704 Extracting and purification of triene steroids from mammal urine by chromatography; hormone replacement therapy |
| 02/10/2005 | US20050032767 Method for obtaining a natural mixture of conjugated equine estrogens |
| 02/10/2005 | US20050032761 Lipid profile modulation |
| 02/10/2005 | US20050032760 Continuous process for the production of r-rofleponide |
| 02/10/2005 | US20050032755 Dosage regimen and pharmaceutical composition for emergency contraception |
| 02/09/2005 | EP1504019A1 Platinum complexes having antitumor activity |
| 02/09/2005 | EP1370268A4 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 02/08/2005 | US6852710 Antitumor agents, anticancer agents |
| 02/03/2005 | WO2005010021A1 Method for obtaining a natural mixture of conjugated equine estrogens |
| 02/03/2005 | WO2004096829A3 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 02/03/2005 | US20050026891 Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy |
| 02/02/2005 | EP1501859A1 17a-FLUOROALKYL-11BETA-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 02/02/2005 | CN1187053C Uses of sugar cortexin receptor antagon for production of phrenopathic medicine |
| 01/27/2005 | US20050020555 Estrogenic compounds as anti-mitotic agents |
| 01/26/2005 | EP1499338A1 7-hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof |
| 01/25/2005 | US6846812 7-Oxo-DHEA compounds for treating keratinous conditions/afflictions |
| 01/25/2005 | CA2188981C Isomerisation of equilin |
| 01/20/2005 | WO2005005452A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005005451A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005005449A2 Steroid modified solatrioses |
| 01/20/2005 | US20050014776 Steroidal compounds for inhibiting steroid sulphatase |
| 01/20/2005 | US20050014737 Antiangiogenic agents |
| 01/20/2005 | CA2529358A1 Steroid modified solatrioses |
| 01/19/2005 | EP1497308A1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 01/19/2005 | CN1185249C Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 01/18/2005 | US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 01/18/2005 | US6844334 Compositions of matter including compounds of the present invention are also provided as are methods of treating mammals in need of treatment using compounds of the present invention. |
| 01/13/2005 | WO2005003148A1 Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs |
| 01/13/2005 | US20050009801 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer. |
| 01/13/2005 | CA2530817A1 Microbial process for the preparation of 7-keto dehydroepiandrosterone and related analogs |
| 01/12/2005 | CN1563071A 17-methyl-5 alpha-androstane-16-olefin-3-ketone and preparation method |
| 01/12/2005 | CN1563070A Androstane 4 ene-3 beta, 6 beta, 17 beta-trihydric alcohol and preparation method |
| 01/06/2005 | WO2005000868A1 Process for the synthesis of high purity d-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 01/06/2005 | WO2005000245A2 Compositions and methods for increasing telomerase activity |
| 01/06/2005 | US20050004376 Process for the production of oxandrolone |
| 01/06/2005 | CA2528952A1 Process for the synthesis of high purity d-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpre:gn-4-ene-20-yne-3-one-oxime |
| 01/06/2005 | CA2528657A1 Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters |
| 12/30/2004 | US20040266744 useful as intermediates in the preparation of steroids having medicinal properties |
| 12/30/2004 | US20040266025 Screening and treatment methods for prevention of preterm delivery |
| 12/29/2004 | EP1491551A1 Estrone derivative and process for producing the same |